Olmesartan Medoxomilo Zidrium Teva

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomilo Zidrium Teva, is an angiotensin II receptor blocker presented as a tablet for oral use. It is employed in the management of hypertension in adult patients. GNH USA supplies Olmesartan Medoxomilo Zidrium Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Medoxomilo Zidrium Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan medoxil is an angiotensin II receptor antagonist used in cardiovascular therapy.

- Hypertension: lowers blood pressure and reduces risk of stroke and heart attack. - Diabetic nephropathy: slows progression of kidney damage associated with diabetes. - Heart failure: assists in managing fluid overload and improves cardiac output. - Post‑myocardial infarction: helps prevent adverse remodeling of the heart after a heart attack. - Chronic kidney disease: contributes to blood pressure control in patients with renal impairment.

Olmesartan medoxil may exhibit several adverse reactions.

Common Side Effects: - Headache   - Dizziness   - Fatigue   - Nausea   - Upper  

Serious or Rare